Amedisys (AMED) Catches Eye: Stock Gains 6.2% in Session
Amedisys, Inc. AMED was a big mover last session, as its shares rose over 6% on the day. The move came after the company reported an earnings beat in fourth-quarter 2016 results. This also led to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 12% in the past one-month time frame.
The company has seen one positive and one negative estimate revision in the past 30 days, while its Zacks Consensus Estimate remained unchanged over the same timeframe. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Amedisys currently carries a Zacks Rank #3 (Hold).
Amedisys Inc Price
Amedisys Inc Price | Amedisys Inc Quote
A better-ranked stock in the Medical – Outpatient and Home Healthcare space is Chemed Corp. CHE, carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is AMED going up? Or down? Predict to see what others think: Up or Down
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2017?
Who wouldn't? Last year's market-beating Top 10 portfolio produced 5 double-digit winners. For example, oil and natural gas giant Pioneer Natural Resources and First Republic Bank racked up stellar gains of +44.9% and +44.3% respectively. Now a brand-new list for 2017 has been hand-picked from 4,400 companies covered by the Zacks Rank. See the 2017 Top 10 right now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amedisys Inc (AMED): Free Stock Analysis Report
Chemed Corp. (CHE): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
